+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wearable Injectors Market by Type(On-body, Off-body), Technology (Spring, Motor Drive, Expanding Battery, Rotary Pump), Indications (Diabetes, Immuno-Oncology, Cardiovascular, Chronic Pain), End Users (Hospital & Clinic, Homecare) - Forecast to 2029

  • PDF Icon

    Report

  • 237 Pages
  • February 2024
  • Region: Global
  • Markets and Markets
  • ID: 5396970
Description Jump to:
The global wearable injectors market is projected to reach USD 15.1 billion by 2029 from USD 8.4 billion in 2023, at a CAGR of 10.3% during the forecast period. Precise, user-friendly design, efficient delivery of large molecules, favorable reimbursements, numerous applications in drug delivery, the seamless subcutaneous flow of drugs, rise in the adoption of chronic diseases, and increased adoption of convenient drug delivery devices. The increased cost of wearable injectors and the high use of injection pens are challenges to growth in wearable injectors.

On body wearable injectors segment accounted for the largest share and is expected to grow at the highest rate during the forecast period

On-body injectors, often equipped with the wisdom of smart features, offer a window into medication administration and adherence. Missed doses become a distant memory, usage patterns focus, and timely reminders keep the treatment waltz in rhythm, leading to improved health and fewer complications. Miniaturization promises a lighter, more discreet, while advancements in data security and accessibility will break down the barriers to entry. As manufacturers focus on affordability and diverse needs, on-body injectors have the potential to democratize healthcare, empowering millions to take control of their health with newfound confidence and independence.

The rotary pump segment accounted for the highest growth during the forecast period

Unlike spring-based or motor-driven systems, rotary pumps deliver unwavering accuracy in medication dosage. Their fluid mechanics ensure consistent flow, minimizing the risk of errors and maximizing therapeutic effectiveness, particularly for medications requiring precise micro-doses. will drive the growth of the wearable injectors market. Rotary pumps achieve this magic with their smooth, low-pressure delivery, reducing pain and discomfort for patients, especially those with needle anxieties. Plus, their compact design translates to discreet and convenient use, seamlessly integrating into daily routines.

Immuno oncology segment accounted for the second largest share of the market

Wearable injectors, with their user-friendly designs and intuitive interfaces, become an extension of the patient's therapeutic rhythm, reducing the dissonance of missed doses and ensuring sustained efficacy. This harmonization potentially amplifies treatment outcomes, particularly in immuno-oncology where precise administration is crucial. However, the score of healing can be laced with discomfort, a disruptive counterpoint for patients already battling their disease. Here, wearable injectors offer a gentle counter-melody. Their low-pressure delivery minimizes the cacophonous notes of injection anxiety, allowing patients to focus on the therapeutic crescendo within. This newfound autonomy, the ability to self-administer at their own tempo, liberates patients from the clinical constraints, transforming them into soloists in their own health journey.

Hospitals and clinics are the end-user segment held the largest market share in the wearable injectors market

Wearable injectors are quietly claiming center stage, emerging as discreet allies in chronic disease management. These compact companions, adhering directly to the body, orchestrate medication delivery with precision, often minimizing the overall number of injections and granting patients an unprecedented level of control over their treatment. The allure of these miniature maestros lies in their ability to transcend the confines of hospital walls. Imagine ditching the sterile atmosphere and lengthy waits for home-based medication administration. Wearable injectors liberate patients from the shackles of institutional routines, reducing unnecessary clinic visits and the associated risk of hospital-acquired infections. This shift not only empowers individuals but also aligns with the digital health revolution, paving the way for seamless connectivity and remote monitoring of chronic conditions.

North America to Witness Significant Growth From 2023 to 2029

Wearable injectors market has been segmented into five major regional segments: North America, Europe, Asia Pacific, Latin America and Middle East and Africa and GCC. In 2022, the Asia Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR) during the forecast period. However, the North American market held the largest market share of the global market. North America stands as the frontrunner in the wearable injectors market, commanding the largest market share throughout the forecast period. North America boasts a well-developed healthcare infrastructure, fertile ground for nurturing research and development of cutting-edge technologies. Leading manufacturers find a welcoming stage here, their expertise fueling a thriving ecosystem of collaboration with universities, research labs, and other industry players. This collaborative spirit results in a constant crescendo of innovation, propelling the wearable injector market forward.

Breakdown of supply-side primary interviews:

  • By Company Type: Tier 1 - 35%, Tier 2 - 50%, and Tier 3 - 15%
  • By Designation: C-level - 35%, Director-level - 40%, and Others - 25%
  • By Region: North America - 30%, Europe - 25%, APAC - 20%, Latin America - 15%, Middle East & Africa - 7%, GCC - 3%
Some of the prominent players in the wearable injectors market are Amgen Inc. (US), Medtronic PLC (Europe), Insulet Corporation (US), Tandem Diabetes Care, Inc. (US), United Therapeutics Corporation (US), Abbvie Inc. (US), Gerresheimer AG (Germany), Becton Dickinson and Company (US), West Pharmaceutical Services Inc. (US), Ypsomed AG (Switzerland), Enable Injections (US), Subcuject APS (Denmark), Cequr Simplicity (Switzerland), Mannkind Corporation (US), Sonceboz (Switzerland), CC Bio (Japan), Elcam Drug Delivery Devices (Israel), Stevanato Group (Italy), Debiotech SA (Switzerland), Bexson Biomedical (US), Nemera (France), LTS Lohmann Therapie Systeme AG (Germany), Kymanox Corporation (US), Novo Engineering (US), and Eoflow (South Korea).

Research Coverage

This report studies the wearable injectors market based on type, technology, indication, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and respective countries.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:

  • Analysis of key drivers (increasing prevalence of diabetes, technological advancements in wearable injectors devices, advent of artificial intelligence in wearable injectors, favorable reimbursements scenario in major markets, low-complexity, easy-to-use wearable injection platform), restraints (high cost of wearable injectors, oral insulin as an alternative drug delivery method), opportunities (increasing research and development activities and strategic partnerships and increased adoption of on-body wearable injectors), and challenges (needlestick injuries and misuse of injection pens) influencing the growth of wearable injectors market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in wearable injectors market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of respiratory diagnostics across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in wearable injectors market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the wearable injectors market.

Table of Contents

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Inclusions & Exclusions
1.4 Market Scope
1.4.1 Markets Covered
1.4.2 Regions Covered
1.4.3 Years Considered
1.4.4 Currency Considered
Table 1 Exchange Rates Utilized for Conversion to USD
1.5 Stakeholders
1.6 Summary of Changes
1.6.1 Recession Impact: Wearable Injectors Market
2 Research Methodology
2.1 Research Data
Figure 1 Research Design
2.1.1 Secondary Data
2.1.1.1 Key Data from Secondary Sources
2.1.2 Primary Data
Figure 2 Primary Sources
2.1.2.1 Key Data from Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primary Interviews
Figure 3 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 4 Breakdown of Primary Interviews: by End-user, Designation, and Region
Figure 5 Breakdown of Primary Interviews: Supply-Side and Demand-Side Participants
2.2 Market Size Estimation
Figure 6 Supply-Side Market Size Estimation: Revenue Share Analysis
Figure 7 Revenue Share Analysis Illustration: Amgen Inc.
Figure 8 Supply-Side Analysis of Top Companies: Wearable Injectors Market (2022)
Figure 9 CAGR Projections from Analysis of Drivers, Restraints, Opportunities, and Challenges, 2023-2029
Figure 10 CAGR Projections: Supply-Side Analysis
Figure 11 Top-Down Approach
2.3 Data Triangulation
Figure 12 Market Data Triangulation
2.4 Market Share Estimation
2.5 Study Assumptions
2.6 Research Limitations
2.6.1 Methodology-Related Limitations
2.6.2 Scope-Related Limitations
2.7 Risk Assessment
Table 2 Risk Assessment: Wearable Injectors Market
2.8 Impact of Economic Recession on Wearable Injectors Market
3 Executive Summary
Figure 13 Wearable Injectors Market, by Type, 2023 vs. 2029 (USD Million)
Figure 14 Wearable Injectors Market, by Technology, 2023 vs. 2029 (USD Million)
Figure 15 Wearable Injectors Market, by Indication, 2023 vs. 2029 (USD Million)
Figure 16 Wearable Injectors Market, by End-user, 2023 vs. 2029 (USD Million)
Figure 17 Regional Snapshot of Wearable Injectors Market
4 Premium Insights
4.1 Wearable Injectors Market Overview
Figure 18 Increasing Prevalence of Chronic Diseases and Rising Healthcare Expenditure to Drive Market
4.2 Asia-Pacific: Wearable Injectors Market, by End-user & Region, 2022
Figure 19 China and Hospitals and Clinics Accounted for Largest Share of Asia-Pacific Market in 2022
4.3 Geographic Growth Opportunities: Wearable Injectors Market
Figure 20 US to Register Highest Market Growth Rate During Forecast Period
4.4 Wearable Injectors Market: Developed vs. Emerging Economies
Figure 21 Emerging Economies to Register Higher Growth Rates During Study Period
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 22 Drivers, Restraints, Opportunities, & Challenges: Wearable Injectors Market
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Diabetes Among Geriatric Population
Table 3 Top Five Countries with Highest Number of Diabetes Patients (20-79 Years), 2021 vs. 2045
5.2.1.2 Technological Advancements in Wearable Injectors
5.2.1.3 Use of Artificial Intelligence in Diabetes Care Devices
5.2.1.4 Favorable Reimbursement Scenario
5.2.1.5 Development of Low-Complexity and Easy-To-Use Wearable Injectors
5.2.2 Restraints
5.2.2.1 High Cost of Wearable Injectors and Lack of Reimbursement Plans in Emerging Economies
5.2.2.2 Increased Focus on Alternative Drug Delivery Methods
5.2.3 Opportunities
5.2.3.1 Increased Number of R&D Activities and Strategic Partnerships
5.2.3.2 Growing Adoption of On-Body Wearable Injectors
5.2.4 Challenges
5.2.4.1 Lack of Training and Education for Using New Delivery Devices
5.3 Industry Trends
5.3.1 Increasing Adoption of Wearable Drug Delivery Systems
5.3.2 Rising Number of Collaborations Among Stakeholders
Table 4 Recent Collaborations in Wearable Injectors Market
5.3.3 Integration of Liquid Silicone Rubber Technology in Wearable Health Monitoring and Drug Delivery Devices
5.4 Technology Analysis
5.5 Supply Chain Analysis
Figure 23 Supply Chain Analysis: Wearable Injectors Market
5.6 Value Chain Analysis
Figure 24 Value Chain Analysis: Wearable Injectors Market
5.7 Ecosystem Market/Map
Figure 25 Ecosystem Market/Map: Wearable Injectors Market
5.8 Trade Analysis
Table 5 Import and Export Data for Wearable Injectors, by Country
5.9 Porter's Five Forces Analysis
Table 6 Porter's Five Forces Analysis: Wearable Injectors Market
5.9.1 Intensity of Competitive Rivalry
5.9.2 Bargaining Power of Suppliers
5.9.3 Bargaining Power of Buyers
5.9.4 Threat of Substitutes
5.9.5 Threat of New Entrants
5.10 Tariff & Regulatory Landscape
5.10.1 Regulatory Analysis
5.10.1.1 North America
5.10.1.1.1 US
5.10.1.1.2 Canada
5.10.1.2 Europe
5.10.1.3 Asia-Pacific
5.10.1.3.1 China
5.10.1.3.2 Japan
5.10.1.3.3 India
5.10.1.4 Latin America
5.10.1.4.1 Brazil
5.10.1.4.2 Mexico
5.10.1.5 Middle East
5.10.1.6 Africa
5.10.2 Regulatory Bodies, Government Agencies, and Other Organizations
Table 7 North America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 8 Europe: Regulatory Bodies, Government Agencies, and Other Organizations
Table 9 Asia-Pacific: Regulatory Bodies, Government Agencies, and Other Organizations
Table 10 Latin America: Regulatory Bodies, Government Agencies, and Other Organizations
Table 11 Middle East: Regulatory Bodies, Government Agencies, and Other Organizations
5.11 Patent Analysis
5.11.1 Patent Publication Trends for Wearable Injectors
Figure 26 Patent Publication Trends (January 2018-May 2023)
5.11.2 Top Applicants (Companies) for Wearable Injector Patents
Figure 27 Top Applicant Companies for Wearable Injector Patents, 2018-2023
5.11.3 Jurisdiction Analysis: Top Applicants (Countries) for Wearable Injector Patents
Figure 28 Jurisdiction Analysis: Top Applicant Countries for Wearable Injector Patents, 2018-2023
5.12 Pricing Analysis
5.12.1 Average Selling Price of Wearable Injectors, by Key Player
Table 12 Average Selling Price of Wearable Injectors, by Key Players, 2022
5.13 Key Conferences & Events, 2023-2024
Table 13 Detailed List of Key Conferences & Events in Wearable Injectors Market, 2023-2024
5.14 Key Stakeholders & Buying Criteria
5.14.1 Key Stakeholders in Buying Process
Figure 29 Influence of Stakeholders on Buying Process for Top Three Diseases
Table 14 Influence of Stakeholders on Buying Process for Top Three Diseases (%)
5.14.2 Buying Criteria
Figure 30 Key Buying Criteria for Top Three Diseases
Table 15 Key Buying Criteria for Top Three Diseases
5.15 Trends/Disruptions Impacting Customers’ Businesses
5.16 Unmet Needs
5.17 Adjacent Market Analysis
Figure 31 Adjacent Markets to Wearable Injectors Market
6 Wearable Injectors Market, by Type
6.1 Introduction
Table 16 Wearable Injectors Market, by Type, 2021-2029 (USD Million)
6.2 On-Body Wearable Injectors
6.2.1 On-Body Wearable Injectors to Command Largest Market Share During Forecast Period
Table 17 Wearable Injectors Market for On-Body Wearable Injectors, by Country, 2021-2029 (USD Million)
6.3 Off-Body Wearable Injectors
6.3.1 Easy and Continuous Drug Delivery at Regular Intervals to Drive Market
Table 18 Wearable Injectors Market for Off-Body Wearable Injectors, by Country, 2021-2029 (USD Million)
6.4 Device-Only Wearable Injectors
6.4.1 Ease of Administration to Support Market Growth
Table 19 Wearable Injectors Market for Device-Only Wearable Injectors, by Country, 2021-2029 (USD Million)
7 Wearable Injectors Market, by Technology
7.1 Introduction
Table 20 Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
7.2 Spring-based Technology
7.2.1 Minimal Discomfort and Anxiety for Patients with Needle Phobia to Propel Market
Table 21 Wearable Injectors Market for Spring-based Technology, by Country, 2021-2029 (USD Million)
7.3 Motor-Driven Technology
7.3.1 Technological Advancements and Improved Safety to Aid Market Growth
Table 22 Wearable Injectors Market for Motor-Driven Technology, by Country, 2021-2029 (USD Million)
7.4 Rotary Pump Technology
7.4.1 Higher Precision and Better Control Over Viscous Medicines to Support Market Growth
Table 23 Wearable Injectors Market for Rotary Pump Technology, by Country, 2021-2029 (USD Million)
7.5 Expanding Battery Technology
7.5.1 Reduced Production Cost and Ease of Usage to Drive Market
Table 24 Wearable Injectors Market for Expanding Battery Technology, by Country, 2021-2029 (USD Million)
7.6 Other Technologies
Table 25 Wearable Injectors Market for Other Technologies, by Country, 2021-2029 (USD Million)
8 Wearable Injectors Market, by Indication
8.1 Introduction
Table 26 Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
8.2 Diabetes
8.2.1 High Prevalence of Diabetes to Drive Market
Table 27 Insulin Devices Available for Diabetic Patients
Table 28 Wearable Injectors Market for Diabetes, by Country, 2021-2029 (USD Million)
8.3 Immuno-Oncology
8.3.1 Increasing Number of Cancer Cases to Boost Market Growth
Table 29 Wearable Injectors Market for Immuno-Oncology, by Country, 2021-2029 (USD Million)
8.4 Cardiovascular Diseases
8.4.1 Rising Cases of Heart Failure Among Adults to Propel Market Growth
Table 30 Wearable Injectors Market for Cardiovascular Diseases, by Country, 2021-2029 (USD Million)
8.5 Chronic Pains
8.5.1 Increasing Research in Pain Management to Support Market Growth
Table 31 Wearable Injectors Market for Chronic Pains, by Country, 2021-2029 (USD Million)
8.6 Other Diseases
Table 32 Wearable Injectors Market for Other Diseases, by Country, 2021-2029 (USD Million)
9 Wearable Injectors Market, by End-user
9.1 Introduction
Table 33 Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
9.2 Hospitals and Clinics
9.2.1 Hospitals and Clinics to Command Largest End-user Segment of End-user During Study Period
Table 34 Wearable Injectors Market for Hospitals and Clinics, by Country, 2021-2029 (USD Million)
9.3 Home Care Settings
9.3.1 Rising Preference for Self-Administration of Medicine to Drive Market
Table 35 Wearable Injectors Market for Home Care Settings, by Country, 2021-2029 (USD Million)
9.4 Other End-users
Table 36 Wearable Injectors Market for Other End-users, by Country, 2021-2029 (USD Million)
10 Wearable Injectors Market, by Region
10.1 Introduction
Figure 32 Wearable Injectors Market: Regional Snapshot
Table 37 Wearable Injectors Market, by Region, 2021-2029 (USD Million)
10.2 North America
Figure 33 North America: Wearable Injectors Market Snapshot
Table 38 North America: Wearable Injectors Market, by Country, 2021-2029 (USD Million)
Table 39 North America: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 40 North America: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 41 North America: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 42 North America: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.2.1 North America: Recession Impact
10.2.2 US
10.2.2.1 Favorable Reimbursement Scenario and High Prevalence of Chronic Diseases to Drive Market
Table 43 US: Key Macroindicators
Table 44 US: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 45 US: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 46 US: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 47 US: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.2.3 Canada
10.2.3.1 Growing Biologics Market to Propel Market Growth
Table 48 Canada: Key Macroindicators
Table 49 Canada: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 50 Canada: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 51 Canada: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 52 Canada: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3 Europe
Table 53 Europe: Wearable Injectors Market, by Country, 2021-2029 (USD Million)
Table 54 Europe: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 55 Europe: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 56 Europe: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 57 Europe: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.1 Europe: Recession Impact
10.3.2 Germany
10.3.2.1 Favorable Government Policies for Drug Development and Approval to Aid Market Growth
Table 58 Germany: Key Macroindicators
Table 59 Germany: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 60 Germany: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 61 Germany: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 62 Germany: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.3 France
10.3.3.1 Increased Prevalence of Diabetes and Favorable Insurance Coverage by Shi to Drive Market
Table 63 France: Key Macroindicators
Table 64 France: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 65 France: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 66 France: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 67 France: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.4 UK
10.3.4.1 Rising Focus on Development and Promotion of Biosimilars and Biologics to Propel Market Growth
Table 68 UK: Key Macroindicators
Table 69 UK: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 70 UK: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 71 UK: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 72 UK: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.5 Italy
10.3.5.1 Rising Prevalence of Diabetes to Support Market Growth
Table 73 Italy: Macroeconomic Indicators
Table 74 Italy: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 75 Italy: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 76 Italy: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 77 Italy: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.6 Spain
10.3.6.1 Increased Preference for Less Painful Drug Delivery Systems Among Geriatric Population to Drive Market
Table 78 Spain: Macroeconomic Indicators
Table 79 Spain: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 80 Spain: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 81 Spain: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 82 Spain: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.3.7 Rest of Europe
Table 83 Rest of Europe: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 84 Rest of Europe: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 85 Rest of Europe: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 86 Rest of Europe: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4 Asia-Pacific
Figure 34 Asia-Pacific: Wearable Injectors Market Snapshot
Table 87 Asia-Pacific: Wearable Injectors Market, by Country, 2021-2029 (USD Million)
Table 88 Asia-Pacific: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 89 Asia-Pacific: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 90 Asia-Pacific: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 91 Asia-Pacific: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.1 Asia-Pacific: Recession Impact
10.4.2 Japan
10.4.2.1 Increasing Number of Patients Suffering from Diabetes, Cvd, and Chronic Conditions to Drive Market
Table 92 Japan: Macroeconomic Indicators
Table 93 Japan: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 94 Japan: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 95 Japan: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 96 Japan: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.3 China
10.4.3.1 Favorable Government Initiatives and Improved Access to Advanced Healthcare to Drive Market
Table 97 China: Macroeconomic Indicators
Table 98 China: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 99 China: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 100 China: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 101 China: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.4 India
10.4.4.1 Growing Burden of Diabetes and Increasing Need to Reduce Healthcare Costs to Propel Market
Table 102 India: Macroeconomic Indicators
Table 103 India: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 104 India: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 105 India: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 106 India: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.5 Australia
10.4.5.1 Favorable Government Initiatives for Diabetes Treatment to Drive Market
Table 107 Australia: Macroeconomic Indicators
Table 108 Australia: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 109 Australia: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 110 Australia: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 111 Australia: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.6 South Korea
10.4.6.1 Increased Number of Government Initiatives for Diabetes Management to Drive Market
Table 112 South Korea: Key Macroindicators
Table 113 South Korea: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 114 South Korea: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 115 South Korea: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 116 South Korea: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.4.7 Rest of Asia-Pacific
Table 117 Rest of Asia-Pacific: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 118 Rest of Asia-Pacific: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 119 Rest of Asia-Pacific: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 120 Rest of Asia-Pacific: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.5 Latin America
Table 121 Latin America: Wearable Injectors Market, by Country, 2021-2029 (USD Million)
Table 122 Latin America: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 123 Latin America: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 124 Latin America: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 125 Latin America: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.5.1 Latin America: Recession Impact
10.5.2 Brazil
10.5.2.1 Increasing Number of Government Initiatives for Improving Healthcare Sector to Boost Market
Table 126 Brazil: Macroeconomic Indicators
Table 127 Brazil: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 128 Brazil: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 129 Brazil: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 130 Brazil: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.5.3 Mexico
10.5.3.1 Increasing Prevalence of Diabetes and Obesity-Related Diseases to Boost Market Growth
Table 131 Mexico: Key Macroindicators
Table 132 Mexico: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 133 Mexico: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 134 Mexico: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 135 Mexico: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.5.4 Rest of Latin America
Table 136 Rest of Latin America: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 137 Rest of Latin America: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 138 Rest of Latin America: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 139 Rest of Latin America: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.6 Middle East & Africa
Table 140 Middle East & Africa: Wearable Injectors Market, by Region, 2021-2029 (USD Million)
Table 141 Middle East & Africa: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 142 Middle East & Africa: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 143 Middle East & Africa: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 144 Middle East & Africa: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.6.1 Middle East & Africa: Recession Impact
10.6.2 GCC Countries
10.6.2.1 Growing Incidence of Chronic Diseases to Propel Market
Table 145 GCC Countries: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 146 GCC Countries: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 147 GCC Countries: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 148 GCC Countries: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
10.6.3 Rest of Middle East & Africa
Table 149 Rest of Middle East & Africa: Wearable Injectors Market, by Type, 2021-2029 (USD Million)
Table 150 Rest of Middle East & Africa: Wearable Injectors Market, by Technology, 2021-2029 (USD Million)
Table 151 Rest of Middle East & Africa: Wearable Injectors Market, by Indication, 2021-2029 (USD Million)
Table 152 Rest of Middle East & Africa: Wearable Injectors Market, by End-user, 2021-2029 (USD Million)
11 Competitive Landscape
11.1 Introduction
11.2 Key Strengths/Right to Win
Figure 35 Strategies Adopted by Key Players in Wearable Injectors Market, 2020-2024
11.3 Revenue Share Analysis
Figure 36 Revenue Share Analysis of Key Players, 2018-2022
11.4 Market Share Analysis
Figure 37 Market Share Analysis of Key Players, 2022
11.5 Manufacturers of Wearable Devices
Table 153 List of Key Manufacturers of Wearable Devices
11.6 Company Evaluation Matrix
11.6.1 Stars
11.6.2 Emerging Leaders
11.6.3 Pervasive Players
11.6.4 Participants
Figure 38 Company Evaluation Matrix, 2022
11.6.5 Company Footprint
Table 154 Wearable Injectors Market: Overall Footprint
Table 155 Wearable Injectors Market: Product Footprint
Table 156 Wearable Injectors Market: Regional Footprint
11.7 Start-Up/SME Evaluation Matrix
11.7.1 Progressive Companies
11.7.2 Responsive Companies
11.7.3 Dynamic Companies
11.7.4 Starting Blocks
Figure 39 Start-Up/SME Evaluation Matrix, 2022
11.7.5 Competitive Benchmarking
Table 157 Detailed List of Key Start-Ups/SMEs
11.8 R&D Expenditure
Figure 40 R&D Expenditure of Key Players, 2021 vs. 2022
11.9 Brand/Product Comparison
Table 158 Brand/Product Comparison of Key Players
11.9.1 Amgen Inc.
11.9.2 Medtronic
11.9.3 Insulet Corporation
11.9.4 Tandem Diabetes Care, Inc.
11.9.5 United Therapeutics
11.9.6 Abbvie Inc.
11.9.7 Gerresheimer AG
11.10 Investment and Funding Scenario
Figure 41 Funding in Wearable Injectors Market Soared in 2022
11.10.1 Funding in Wearable Injectors Market, by Indication
Table 159 Funding in Wearable Injectors Market, by Indication
Figure 42 Most Valued Wearable Injectors Firms in 2022 (USD Billion)
11.11 Company Financial Metrics
Figure 43 Financial Metrics of Key Companies, 2022
11.12 Competitive Scenario
11.12.1 Product Launches & Approvals
Table 160 Wearable Injectors Market: Product Launches & Approvals, 2020-2024
11.12.2 Deals
Table 161 Wearable Injectors Market: Deals, 2020-2024
11.12.3 Other Developments
Table 162 Wearable Injectors Market: Other Developments, 2020-2024
12 Company Profiles
12.1 Key Players
(Business Overview, Products/Solutions/Services Offered, Recent Developments, Deals, Analyst's View, Key Strengths/Right to Win, Strategic Choices, and Weaknesses and Competitive Threats)*
12.1.1 Amgen Inc.
Table 163 Amgen Inc.: Company Overview
Figure 44 Amgen Inc.: Company Snapshot (2022)
Table 164 Amgen Inc.: Deals, 2020-2024
Table 165 Amgen Inc.: Other Developments, 2020-2024
12.1.2 Medtronic
Table 166 Medtronic: Company Overview
Figure 45 Medtronic: Company Snapshot (2022)
Table 167 Medtronic: Product Launches & Approvals, 2020-2024
Table 168 Medtronic: Deals, 2020-2024
12.1.3 Insulet Corporation
Table 169 Insulet Corporation: Company Overview
Figure 46 Insulet Corporation: Company Snapshot (2022)
Table 170 Insulet Corporation: Product Launches & Approvals, 2020-2024
Table 171 Insulet Corporation: Deals, 2020-2024
12.1.4 Tandem Diabetes Care, Inc.
Table 172 Tandem Diabetes Care, Inc.: Company Overview
Figure 47 Tandem Diabetes Care, Inc.: Company Snapshot (2022)
Table 173 Tandem Diabetes Care, Inc.: Deals, 2020-2024
12.1.5 United Therapeutics Corporation
Table 174 United Therapeutics Corporation: Company Overview
Figure 48 United Therapeutics Corporation: Company Snapshot (2022)
Table 175 United Therapeutics Corporation: Deals, 2020-2024
12.1.6 Abbvie Inc.
Table 176 Abbvie Inc.: Company Overview
Figure 49 Abbvie Inc.: Company Snapshot (2022)
Table 177 Abbvie Inc.: Product Launches & Approvals, 2020-2024
12.1.7 Gerresheimer AG
Table 178 Gerresheimer AG: Company Overview
Figure 50 Gerresheimer AG: Company Snapshot (2022)
Table 179 Gerresheimer AG: Product Launches & Approvals, 2020-2024
Table 180 Gerresheimer AG: Deals, 2020-2024
12.1.8 Becton, Dickison and Company
Table 181 Becton, Dickinson and Company: Company Overview
Figure 51 Becton, Dickinson and Company: Company Snapshot (2022)
Table 182 Becton, Dickinson and Company: Deals, 2020-2024
Table 183 Becton, Dickinson and Company: Other Developments, 2020-2024
12.1.9 West Pharmaceutical Services, Inc.
Table 184 West Pharmaceutical Services, Inc.: Company Overview
Figure 52 West Pharmaceutical Services, Inc.: Company Snapshot (2022)
12.1.10 Ypsomed Holding AG
Table 185 Ypsomed Holding AG: Company Overview
Figure 53 Ypsomed Holding AG: Company Snapshot (2022)
Table 186 Ypsomed Holding AG: Product Launches & Approvals, 2020-2024
Table 187 Ypsomed Holding AG: Deals, 2020-2024
Table 188 Ypsomed Holding AG: Other Developments, 2020-2024
12.1.11 Enable Injections
Table 189 Enable Injections: Company Overview
Table 190 Enable Injections: Product Launches & Approvals, 2020-2024
Table 191 Enable Injections: Deals, 2020-2024
Table 192 Enable Injections: Other Developments, 2020-2024
12.1.12 Subcuject Aps
Table 193 Subcuject Aps: Company Overview
12.1.13 Cequr Simplicity
Table 194 Cequr Simplicity: Company Overview
Table 195 Cequr Simplicity: Other Developments, 2020-2024
12.1.14 Mannkind Corporation
Table 196 Mannkind Corporation: Company Overview
Figure 54 Mannkind Corporation: Company Snapshot (2022)
Table 197 Mannkind Corporation: Deals, 2020-2024
Table 198 Mannkind Corporation: Other Developments, 2020-2024
12.1.15 Sonceboz
Table 199 Sonceboz: Company Overview
12.1.16 Cc Bio
Table 200 Cc Bio: Company Overview
Table 201 Cc Bio: Deals, 2020-2024
12.1.17 Elcam Drug Delivery Devices
Table 202 Elcam Drug Delivery Devices: Company Overview
Table 203 Elcam Drug Delivery Devices: Deals, 2020-2024
12.1.18 Stevanato Group
Table 204 Stevanato Group: Company Overview
12.1.19 Debiotech SA
Table 205 Debiotech SA: Company Overview
12.2 Other Players
12.2.1 Bexson Biomedical
12.2.2 Nemera
12.2.3 Lts Lohmann Therapie-Systeme AG
12.2.4 Kymanox Corporation
12.2.5 Novo Engineering
12.2.6 Eoflow Co. Ltd.
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, Deals, Analyst's View, Key Strengths/Right to Win, Strategic Choices, and Weaknesses and Competitive Threats Might Not be Captured in Case of Unlisted Companies
13 Appendix
13.1 Discussion Guide
13.2 Knowledgestore: The Subscription Portal
13.3 Customization Options

Companies Mentioned

  • Amgen Inc.
  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Abbvie Inc.
  • Gerresheimer AG
  • Becton, Dickison and Company
  • West Pharmaceutical Services, Inc.
  • Ypsomed Holding AG
  • Enable Injections
  • Subcuject Aps
  • Cequr Simplicity
  • Mannkind Corporation
  • Sonceboz
  • Cc Bio
  • Elcam Drug Delivery Devices
  • Stevanato Group
  • Debiotech SA
  • Bexson Biomedical
  • Nemera
  • Lts Lohmann Therapie-Systeme AG
  • Kymanox Corporation
  • Novo Engineering
  • Eoflow Co. Ltd.

Table Information

Report AttributeDetails
No. of Pages237
PublishedFebruary 2024
Forecast Period2023 - 2029
Estimated Market Value ( USD ) in 2023 $ 8.4 Billion
Forecasted Market Value ( USD ) by 2029 $ 15.1 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Wearable Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Wearable Injectors - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Wearable Injector Market by Type, Technology, Application, End-Use, Distribution Channel - Global Forecast 2025-2030 - Product Image

Wearable Injector Market by Type, Technology, Application, End-Use, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Wearable Injectors Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Wearable Injectors Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 151 Pages
  • Global
From
Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On-body, Off-body), Technology (Spring-based, Motor-driven), End-use (Hospitals, Clinics), Application (Oncology), Region, and Segment Forecasts, 2024-2030 - Product Image

Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On-body, Off-body), Technology (Spring-based, Motor-driven), End-use (Hospitals, Clinics), Application (Oncology), Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
Wearable Injectors Market Report by Type, Technology, Application, End Use, and Region 2024-2032 - Product Image

Wearable Injectors Market Report by Type, Technology, Application, End Use, and Region 2024-2032

  • Report
  • 147 Pages
  • Global
From

About the Wearable Injector Market

The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety. Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.